The higher frequency of TP53 R273C in IDH-mutant astrocytomas compared to other TP53 mutations could be related to the production of D-2-hydroxyglutarate (D-2HG) by these tumors. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).